The global breast biopsy market size reached USD 2.96 Billion in 2022 and is expected to register a revenue CAGR of 5.7% during the forecast period, according to the latest analysis by Emergen Research. Growing developments in molecular imaging-related technologies is a key factor driving revenue growth of the market. One of the main factors driving market revenue growth is the expansion of research & development into the creation of breast biopsy platforms to treat chronic breast illnesses. The development of novel technologies is made possible by the rising research activities carried out by numerous institutions around the world. These technologies effectiveness makes it easier for them to enter the market. The market revenue growth is significantly influenced by the rising incidence of breast cancer.
The report discusses in detail the growth opportunities, challenges, market drivers and restraints, limitations, threats, and demands of the Breast Biopsy market. The study further assesses the regional market as well as the international market to garner an insight into the scope of the market. The report also provides deeper insights into the technological advancements, industrial landscape, and emerging product and technological developments in the Breast Biopsy market. It offers fruitful insights into the business sphere to help businesses capitalize on the lucrative growth opportunities.
The global Breast Biopsy industry is highly consolidated owing to the presence of renowned companies operating across several international and local segments of the market. These players dominate the industry in terms of their strong geographical reach and a large number of production facilities. The companies are intensely competitive against one another and excel in their individual technological capabilities, as well as product development, innovation, and product pricing strategies.
The leading market contenders listed in the report are:
Devicor Medical Products, Inc., ARGON MEDICAL., B. Braun Melsungen AG, Cardinal Health., Olympus Corporation, Boston Scientific Corporation, FUJIFILM Corporation, INRAD Inc., Medtronic, Hologic, Inc
Key market aspects studied in the report:
Market Scope: The report explains the scope of various commercial possibilities in the global Breast Biopsy market over the upcoming years. The estimated revenue build-up over the forecast years has been included in the report. The report analyzes the key market segments and sub-segments and provides deep insights into the market to assist readers with the formulation of lucrative strategies for business expansion.
Competitive Outlook: The leading companies operating in the Breast Biopsy market have been enumerated in this report. This section of the report lays emphasis on the geographical reach and production facilities of these companies. To get ahead of their rivals, the leading players are focusing more on offering products at competitive prices, according to our analysts.
Report Objective: The primary objective of this report is to provide the manufacturers, distributors, suppliers, and buyers engaged in this sector with access to a deeper and improved understanding of the global Breast Biopsy market.
This market is segmented based on Types, Applications, and Regions. The growth of each segment provides accurate forecasts related to production and sales by Types and Applications, in terms of volume and value for the period between 2022 and 2030. This analysis can help readers looking to expand their business by targeting emerging and niche markets. Market share data is given on both global and regional levels. Regions covered in the report are North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Research analysts assess the market positions of the leading competitors and provide competitive analysis for each company. For this study, this report segments the global Breast Biopsy market on the basis of product, application, and region:
Segments Covered in this report are:
Type Outlook (Revenue, USD Billion; 2019-2032)
Mammography
MRI
Others
Product Outlook (Revenue, USD Billion; 2019-2032)
Vacuum Assisted Biopsy
Core Needle Biopsy
Others
Regional Outlook (Revenue, USD Billion; 2019–2032)